Marshak Richard
Chief Commercial Officer
Marshak Richard has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Marshak Richard is listed as Chief Commercial Officer at TriSalus Life Sciences, Inc. Inside the rolling window, Marshak Richard reported no open-market purchases and 4 open-market sales totaling $16K in TLSI. The largest disclosed transaction in the window is a sale of 1,589 TLSI shares on Mar 12, 2026, worth $6K.
Companies traded
Other insiders at TLSI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Marshak Richard made?
Marshak Richard has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Marshak Richard trade?
Marshak Richard has filed SEC Form 4 disclosures for 1 company, including TLSI.
When was Marshak Richard's most recent SEC Form 4 filing?
Marshak Richard's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Marshak Richard's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Marshak Richard is listed as Chief Commercial Officer.
What is Marshak Richard's total buy and sell value in the current window?
Inside the rolling retention window, Marshak Richard bought $0 and sold $16K based on SEC Form 4 filings.
What was Marshak Richard's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,589 TLSI shares on 2026-03-12, worth $6K, per SEC Form 4 filings.